5-hydroxytryptamine 3 receptor antagonist

5-hydroxytryptamine 3 receptor antagonist ((hy-DROK-see-TRIP-tuh-meen reh-SEP-ter an-TAG-uh-nist)) is an antiemetic drug that is given during cancer therapy. It's also called type 3 serotonin receptor antagonist.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

The original article is from Wikipedia. To view the original article please click here.
Creative Commons Licence